Treatment of type 1 diabetes mellitus using growth hormone antagonist

Details for Australian Patent Application No. 2003218749 (hide)

Owner PHARMACIA AND UPJOHN COMPANY

Inventors Dunger, David, B.; Acerini, Carlo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003218749

PCT Number PCT/EP03/02599

PCT Pub. Number WO2003/075946

Priority 0205898.0 13.03.02 GB

Filing date 12 March 2003

Wipo publication date 22 September 2003

International Classifications

A61K 038/09 Medicinal preparations containing peptides

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 0205898.0 13.03.02 GB

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003218749

3 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218750-SYSTEM UND VERFAHREN ZUM ENTWICKELN VON DOMANENAPPLIKATIONEN

2003218748-Probiotic delivery system